Market Market Market

Market Quick Take - December 27, 2021

Macro 6 minutes to read
Saxo Strategy Team

Summary:  Equity markets in Europe and the US finished last week with a strong flourish in thin holiday trading, with the US S&P 500 index trading near the record highs, while the megacap-heavy Nasdaq 100 index lags slightly. The final sprint into year-end lies ahead in the coming days as investors ponder the ongoing impact of spiking omicron cases and a dramatic improvement in EU power prices as a flotilla of North American LNG cargoes makes its way to Europe.


What is our trading focus?

Nasdaq 100 (USNAS100.I) and S&P 500 (US500.I) - US equities ended on a new all-time high on 23 December with S&P 500 futures closing at 4,715.75 up almost 27% for the year. This morning US equity futures continue higher despite a hot PCE inflation report before the holiday showing inflation persists in the US economy. US equities are responding positively as the bond market remains muted with the US 10-year yield below 1.5% and flat for the recent period. Liquidity will remain low until after New Year and equity investors are generally preparing for the Q4 earnings season which starts in mid-January and will crucial for understanding whether profit margins continue to go lower due to higher input costs.

Oil and Natural Gas (OIL:xmil) - both Brent and WTI futures have recovered back to important resistance – the lows that were posted prior to the enormous slide generated by the news of the omicron covid variant back at the end of December. The approximate resistance levels are 75 for WTI and 77/bbl for Brent Crude. Elsewhere, Natural Gas and power prices tumbled in Europe late last week as a flotilla of US LNG cargoes is en route to Europe and as milder weather is forecast for most of Europe for the weeks ahead.

USDJPY - the USDJPY pair is over-achieving slightly relative to long US treasury yields, which are higher from recent lows, but where the 10-year US treasury yield has yet to break above 1.50%, much less the cycle high near 1.7% from October. Still, there is little in the way of resistance ahead of the 115.00+ top from November that was harshly rejected on the news of the omicron covid variant. Can USDJPY push to new highs without more support from higher US yields? Critical to note that end-of-year effects may also be in play here for the US dollar.

Gold (XAUUSD) - gold is making a bid to keep our attention in rising above the 1,800 and the 200-day moving average again last week, but heavy lifting required into 1,850+ to impress technically on the chart, together likely with further signs that the market is taking the risk of more durable inflation seriously.

USDTRY – the lira weakened slightly to start this week after its recent wild ride on Turkish president Erdogan’s dramatic intervention and unconventional approach to dealing with the crisis with promises to reimburse lira holders for any losses. Many news sources point to a dramatic drop in reserves as a sign that traditional intervention accompanied the recent measures, to the tune of $5-6 billion. Erdogan has vowed that Turkey will not fight inflation with higher policy rates as recently as Friday.

What is going on?

US Nov. PCE inflation data recap: core inflation remains hot. The US Nov. PCE Inflation data released last Thursday showed this measure of inflation running at +0.6% month-on-month and +5.7% year-on-year, both as expected, while the core inflation reading was +0.5% month-on-month and +4.% year-on-year, versus +0.4%/+4.5% expected, respectively. The Final Dec. University of Michigan survey of inflation expectations saw the 5-10 year median expectation drop back to 2.9% versus the initial 3.0% reading for the month.

Norway Wealth Fund CEO is worried. Nicolai Tangen says in a big interview during the holiday period that the fund is prepared for a decade of lower returns and the biggest threat is inflation, which he sees as not being understood and accepted by the market. He says in the interview that inflation is propping up everywhere and now also in wages and “We have nowhere to hide from inflation”.

EU-Poland tensions increase further. The European Commission (EC) launched an infringement procedure against Poland over a constitutional court ruling. It considers that Poland’s courts are not independent from political influence. Poland now has two months to reply to the letter of formal notice sent by the European Commission. If the Commission is not satisfied with Warsaw’s reply, it can send Poland a reasoned opinion by requesting it to comply with EU law, again with a two-month reply period. The current clash has delayed the release of billions of euros from the EU recovery fund to Poland.

India will overtake France as the sixth largest economic power in the world in 2022, according to the London-based think tank Center for Economics and Business Research, (Access the full report).

India will start vaccinating children between the ages of 15 to 18 from January 3 next year. The country officially recorded 6,987 new daily Covid cases on 25 December. 60.7% of the population have received at least one dose of the vaccine and 41.8% of the population have received two doses.

What are we watching next?

UK has yet to announce new covid restrictions as cases soar - the huge increase in the case count began December 15 and is now running more than twice the prior rate over the last few days, as the rate of hospitalization bears close watching in coming days as a barometer of the risk of new restrictions.

Authorities in France are holding an emergency health defense council today in the afternoon. There are more than 100,000 new daily Covid cases. The incidence rate is at its highest level since the outbreak, at 700. The French National Authority for Health expects Omicron to become the dominant variant in the coming days. New restrictions to contain the pandemic could be announced as soon as today. This could include the reintroduction of gauges in restaurants and cafés, the extension of the closure of night clubs beyond 7 January and the extension of remote work to 3 or 4 days per week, whenever possible. At the moment, the French government does not plan to increase support measures to distressed sectors. Prior to the new wave, France announced a new extension of its employment support scheme while most other European countries have already closed it.

The weekly U.S. initial jobless claims for the week ended 25 December is the main economic release this week. It will be published on 30 December at 1330 GMT. The consensus expects jobless claims to remain unchanged at a seasonally adjusted 205,000.

China’s national legislature, the country's top political advisory body, will convene its annual session on March 5. This is one of the most important macroeconomic and political events in 2022, in our view.

Earnings Watch – no major earnings reports this week and will stay light until the Q4 earnings season starts in mid-January.

Economic calendar highlights for today (times GMT)

1100 – France Nov. Unemployment Rate

1530 – US Dec. Dallas Fed Manufacturing Index

2330 – Japan Nov. Unemployment Rate

2350 – Japan Nov. Industrial Production

 

Follow SaxoStrats on the daily Saxo Markets Call on your favorite podcast app:

Apple Sportify Soundcloud Stitcher

Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.